The new test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques through blood testing, a ...

The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.

The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and Drug Administration (FDA). In a ...

The FDA has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the early detection of the disease in the U.S.

The FDA’s Friday announcement follows an announcement made March 10 by HHS that the agency is revisiting the GRAS final rule for potential reform. Three of the new chemicals that the FDA will study — ...

In a meta-analysis, both the 200-mg and 400-mg doses were effective, although the 400-mg dose was more effective in those with moderate-to-severe kidney disease.

The Food and Drug Administration (FDA) has cleared Lumipulse G for U.S. commercialization as the first blood-based test that ...

The FDA is considering a move that could reshape dental care for children in the US, sparking an outcry among health experts.

Trump is “in peak physical and mental condition,” White House Press Secretary Karoline Leavitt told The Atlantic in an ...

The FDA has cleared a new blood test that would significantly help in diagnosing patients with Alzheimer's disease. Unlike costly PET scans, this simple blood draw detects a key marker of Alzheimer’s.

The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker ...

Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...